BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 34547899)

  • 1. Lipid Cubic Systems for Sustained and Controlled Delivery of Antihistamine Drugs.
    Dully M; Ceresnakova M; Murray D; Soulimane T; Hudson SP
    Mol Pharm; 2021 Oct; 18(10):3777-3794. PubMed ID: 34547899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of antihistamine on up-regulation of histamine H1 receptor mRNA in the nasal mucosa of patients with pollinosis induced by controlled cedar pollen challenge in an environmental exposure unit.
    Kitamura Y; Nakagawa H; Fujii T; Sakoda T; Enomoto T; Mizuguchi H; Fukui H; Takeda N
    J Pharmacol Sci; 2015 Nov; 129(3):183-7. PubMed ID: 26598006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intranasal antihistamine is superior to oral H
    Du K; Qing H; Zheng M; Wang X; Zhang L
    Ann Allergy Asthma Immunol; 2020 Nov; 125(5):589-596.e3. PubMed ID: 32650045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulating the release of pharmaceuticals from lipid cubic phases using a lipase inhibitor.
    Dully M; Brasnett C; Djeghader A; Seddon A; Neilan J; Murray D; Butler J; Soulimane T; Hudson SP
    J Colloid Interface Sci; 2020 Aug; 573():176-192. PubMed ID: 32278949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concomitant corticosteroid nasal spray plus antihistamine (oral or local spray) for the symptomatic management of allergic rhinitis.
    Feng S; Fan Y; Liang Z; Ma R; Cao W
    Eur Arch Otorhinolaryngol; 2016 Nov; 273(11):3477-3486. PubMed ID: 26545381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiallergic effects of H1-receptor antagonists.
    Baroody FM; Naclerio RM
    Allergy; 2000; 55 Suppl 64():17-27. PubMed ID: 11291777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Oral second generation antihistamines in allergic rhinitis].
    Riechelmann H
    Laryngorhinootologie; 2005 Jan; 84(1):30-41. PubMed ID: 15647976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of treatment satisfaction in children with allergic disease treated with an antihistamine: an international, non-interventional, retrospective study.
    Ferrer M; Morais-Almeida M; Guizova M; Khanferyan R
    Clin Drug Investig; 2010; 30(1):15-34. PubMed ID: 19995095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First do no harm: managing antihistamine impairment in patients with allergic rhinitis.
    Casale TB; Blaiss MS; Gelfand E; Gilmore T; Harvey PD; Hindmarch I; Simons FE; Spangler DL; Szefler SJ; Terndrup TE; Waldman SA; Weiler J; Wong DF;
    J Allergy Clin Immunol; 2003 May; 111(5):S835-42. PubMed ID: 12743547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Appraisal of the validity of histamine-induced wheal and flare to predict the clinical efficacy of antihistamines.
    Monroe EW; Daly AF; Shalhoub RF
    J Allergy Clin Immunol; 1997 Feb; 99(2):S798-806. PubMed ID: 9042073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiallergic anti-inflammatory effects of H1-antihistamines in humans.
    Assanasen P; Naclerio RM
    Clin Allergy Immunol; 2002; 17():101-39. PubMed ID: 12113215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antihistamine therapy in allergicĀ rhinitis.
    Hoyte FC; Katial RK
    Immunol Allergy Clin North Am; 2011 Aug; 31(3):509-43. PubMed ID: 21737041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antihistamines: ABC for the pediatricians.
    Parisi GF; Licari A; Papale M; Manti S; Salpietro C; Marseglia GL; Leonardi S
    Pediatr Allergy Immunol; 2020 Feb; 31 Suppl 24():34-36. PubMed ID: 32017222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formulation Development and Evaluation of Diphenhydramine Nasal Nano-Emulgel.
    Javed H; Shah SNH; Iqbal FM
    AAPS PharmSciTech; 2018 May; 19(4):1730-1743. PubMed ID: 29569155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A gap in surface therapy: topical antihistamines.
    Van de Heyning PH; Claes J; Van Haesendonck J; Rosseel M
    Clin Exp Allergy; 1991 May; 21 Suppl 2():21-7. PubMed ID: 1680535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antihistamines in urticaria.
    Ring J; Brockow K; Ollert M; Engst R
    Clin Exp Allergy; 1999 Mar; 29 Suppl 1():31-7. PubMed ID: 10209703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in the pharmacotherapy of allergic rhinitis: second-generation H1-receptor antagonists.
    Corey JP
    Otolaryngol Head Neck Surg; 1993 Sep; 109(3 Pt 2):584-92. PubMed ID: 8105440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antihistamine use in children.
    Fitzsimons R; van der Poel LA; Thornhill W; du Toit G; Shah N; Brough HA
    Arch Dis Child Educ Pract Ed; 2015 Jun; 100(3):122-31. PubMed ID: 25147323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative analysis of the cardiotoxicity proclivities of second generation antihistamines in an experimental model predictive of adverse clinical ECG effects.
    Hey JA; del Prado M; Sherwood J; Kreutner W; Egan RW
    Arzneimittelforschung; 1996 Feb; 46(2):153-8. PubMed ID: 8720304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulatory effect of histamine H1 receptor antagonist on the expression of messenger RNA encoding CC chemokines in the human nasal mucosa.
    Fujikura T; Shimosawa T; Yakuo I
    J Allergy Clin Immunol; 2001 Jan; 107(1):123-8. PubMed ID: 11150001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.